Showing posts with label Diabetes and Obesity Drug Development Market Trends. Show all posts
Showing posts with label Diabetes and Obesity Drug Development Market Trends. Show all posts
Friday, April 7, 2017

Diabetes & Obesity Drug Development Pipeline Review 2016: Ken Research

›
The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type 2 d...